A regulatory role for protease-activated receptor-2 in motivational learning in rats

被引:18
|
作者
Lohman, Rink-Jan [1 ,2 ]
Jones, Nigel C. [2 ]
O'Brien, Terence J. [2 ]
Cocks, Thomas M. [1 ]
机构
[1] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
Protease-activated receptor-2; PAR2; SLIGRL; Trypsin; Protease; Learning; Memory; Anxiety; Elevated-plus maze; Morris water maze; Cerebrospinal fluid; TISSUE-PLASMINOGEN-ACTIVATOR; ELEVATED PLUS-MAZE; LONG-TERM POTENTIATION; ANXIETY-LIKE BEHAVIOR; ONE-TRIAL TOLERANCE; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; MOUSE HIPPOCAMPUS; LATE-PHASE; OPEN-FIELD;
D O I
10.1016/j.nlm.2009.03.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Serine proteases such as tissue plasminogen activator (tPA), thrombin and neuropsin influence hippocampal plasticity involved in learning and memory by facilitating both synaptic remodelling and long-term potentiation. Given our previous findings that trypsin and its receptor, protease-activated receptor-2 (PAR2), are both highly expressed in pyramidal neurons of the hippocampus and that activation of PAR2 attenuates 'pathogenic' plasticity related to epilepsy, we wished to determine the role for PAR2 in normal, non-pathological hippocampal plasticity related to learning and memory. In a strain of rat that show high basal levels of anxiety, the Genetic Absence Epilepsy Rats from Strasbourg (GAERS), peripheral administration of the PAR2 peptide agonist, SLIGRL (1.5 mg/kg s.c.), induced distinct deficits in experience-dependent learning both in the test-retest paradigm of the elevated-plus maze and in the Morris water maze. In separate, conscious rats with indwelling intra-cerebroventricular cannulae, SLIGRL rapidly appeared in cerebrospinal fluid (CSF) following peripheral administration and had a half-life in CSF of approximately 25 min. These results suggest that activation of central PAR2 with brain accessible peptide agonists causes a temporary deficit in the formation and/or recollection of experience-dependent learning and memory. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 50 条
  • [21] Protease-Activated Receptor-2: A Multifaceted Molecular Transducer in the Human
    Andersen, Hjalte H.
    ANNALS OF DERMATOLOGY, 2016, 28 (06) : 771 - 772
  • [22] Protease-activated receptor-2 in rat pancreatic stellate cells
    Masamune, A
    Kikuta, K
    Suzuki, N
    Satoh, M
    Shimosegawa, T
    GASTROENTEROLOGY, 2004, 126 (04) : A596 - A596
  • [23] Protease-activated receptor-2 augments experimental crescentic glomerulonephritis
    Moussa, Leon
    Apostolopoulos, Jim
    Davenport, Piers
    Tchongue, Jorge
    Tipping, Peter G.
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03): : 800 - 808
  • [24] Protease-activated receptor-2 downregulation is associated to vitiligo lesions
    Moretti, Silvia
    Nassini, Romina
    Prignano, Francesca
    Pacini, Alessandra
    Materazzi, Serena
    Naldini, Antonella
    Simoni, Antonella
    Baroni, Gianna
    Pellerito, Silvia
    Filippi, Irene
    Lotti, Torello
    Geppetti, Pierangelo
    Massi, Daniela
    PIGMENT CELL & MELANOMA RESEARCH, 2009, 22 (03) : 335 - 338
  • [25] Fracture healing in protease-activated receptor-2 deficient mice
    O'Neill, Kevin R.
    Stutz, Christopher M.
    Mignemi, Nicholas A.
    Cole, Heather
    Murry, Matthew R.
    Nyman, Jeffry S.
    Hamm, Heidi
    Schoenecker, Jonathan G.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (08) : 1271 - 1276
  • [26] CORRELATION OF SYNOVITIS WITH PROTEASE-ACTIVATED RECEPTOR-2 EXPRESSION IN OSTEOARTHRITIS
    Kelso, Elizabeth B.
    Ferrell, William R.
    Lockhart, John C.
    Walsh, David A.
    Gracie, Alastair J.
    McInnes, Iain B.
    RHEUMATOLOGY, 2009, 48 : I5 - I5
  • [27] Molecular cloning of a protease-activated receptor-2 subtype.
    Compton, SJ
    Cairns, JA
    Palmer, KJ
    Gough, AC
    Darley, M
    Walls, AF
    FASEB JOURNAL, 1999, 13 (04): : A325 - A325
  • [28] Expression of protease-activated receptor-2 during embryonic development
    Jenkins, AL
    Chinni, C
    De Niese, MR
    Blackhart, B
    Mackie, EJ
    DEVELOPMENTAL DYNAMICS, 2000, 218 (03) : 465 - 471
  • [29] Multiple roles for protease-activated receptor-2 in gastric mucosa
    Kawabata A.
    InflammoPharmacology, 2002, 10 (4-6) : 343 - 349
  • [30] A role for protease-activated receptor-2 in thrombin-mediated cytoprotection of vascular endothelium
    Lidington, EA
    Steinberg, R
    Kinderlerer, A
    Landis, C
    Ohba, M
    Samarel, A
    Haskard, DO
    Mason, JC
    RHEUMATOLOGY, 2005, 44 : I21 - I22